Funding for this research was provided by:
Region Sjælland (na)
Received: 15 September 2019
Accepted: 27 January 2020
First Online: 7 February 2020
Ethics approval and consent to participate
: The study was performed in accordance with the guidelines of the Declaration of Helsinki and was approved by the Regional Ethics Committee (no. 50213) Regional Medicines Agency and the Danish Data Protection Agency (REG-81-2015).The use of the two different regimens for induction of labour was approved by the Regional Medicines Agency as standard regimens for the two different departments, therefore individual consent for the choice of medication was not required – besides informed consent for induction of labour in general.All women who participated in the study were asked to fill out a questionnaire abort their birth experience before they left the department. In the end of this questionnaire they were asked for permission to collect information from their medical record. If they did not fill out the questionnaire, they were contacted by telephone and asked to answer the same questions including the question about collecting information from their medical record. The Regional Ethics committee approved the use of verbal consent for data collection, for patients contacted by telephone.All patients included in this study provided informed consent (verbal or written) to access their medical records, and this was collected and registered before data-collection was commenced, as approved by the ethics committee. The researcher accessing the information was/is an authorised health care professional.
: Not applicable.
: The authors declare that they have no competing interests.